Actively Recruiting
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
Led by Columbia University · Updated on 2025-05-13
1000
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
Sponsors
C
Columbia University
Lead Sponsor
G
Gilead Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to describe the long-term health effects of COVID-19 in a population of mostly Black and Latinx individuals and their households who were diagnosed with COVID-19 at Columbia University Irving Medical Center. In New York, the upper Manhattan and south Bronx communities neighboring Columbia University Irving Medical Center (CUIMC) have been two of the most impacted communities of the COVID-19 pandemic. These neighborhoods are predominantly non-Hispanic black or African American and Latinx. This study will invite people who tested positive for COVID-19 and/or were treated at Columbia University Irving Medical Center to: 1) take a survey to ask about current symptoms and any health problems and 2) ask permission to review COVID-related health history including COVID-19 testing results (from the medical record) since infection to learn about health effects after COVID-19 infection; 3) invite anyone in their household to take a survey; and 4) for up to 500 patients who were hospitalized for COVID, give the option of doing a nasal swab to test for SARS-CoV-2 virus and blood test to check for antibody up to 12 months after diagnosis, to compare how results are different 12 months after infection. The goal is to learn about how the severity of person's infection in 2020 influences long term health effects and how others in their household are impacted by COVID-19.
CONDITIONS
Official Title
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years and older
- Have an electronic medical record at New York Presbyterian/Columbia University Irving Medical Center
- Laboratory confirmed COVID-19 infection diagnosed at NYP/CUIMC after March 1, 2020, or diagnosed at least 9 months before completing the online questionnaire
- Able to provide informed consent
- Hospitalized at NYP/CUIMC after March 1, 2020, or diagnosed at least 9 months before completing the questionnaire
- Randomly selected (every 10th) non-hospitalized index case
- Willing to provide nasal swab, blood sample, and complete the questionnaire (for subset)
You will not qualify if you...
- Under 18 years of age
- Not diagnosed with COVID-19
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Columbia University Irving Medical Center
New York, New York, United States, 10032
Actively Recruiting
Research Team
M
Magdalena Sobieszczyk, MD, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here